Oramed PharmaceuticalsORMP
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 47 institutions reported holding Oramed Pharmaceuticals Inc. (ORMP) in their 13F filings, unchanged from Q2 2025. 4 opened new positions and 5 sold out. The largest holders were BML Capital Management, LLC ($8.4M), Aquamarine Financial (Cayman) Ltd ($5.2M) and Murchinson Ltd. ($4.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Oramed Pharmaceuticals Inc.
- CUSIP
- 68403P203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $65K |
| Exits | 5 | $353K |
All 13F filers, Q2 2025 → Q3 2025: 295,593 shares bought and 309,939 shares sold, net −14,346 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| BML Capital Management, LLC | 7.69% | Add +2.7% | 3,167,231 | $8.4M |
| Aquamarine Financial (Cayman) Ltd | 0.53% | — | 1,973,057 | $5.2M |
| Murchinson Ltd. | 0.91% | No change | 1,751,559 | $4.6M |
| Boothbay Fund Management, LLC | 0.06% | No change | 845,391 | $2.2M |
| Rathbones Group PLC | 0.00% | No change | 233,018 | $615K |
| Bank of America Corp. | 0.00% | Add +4.4% | 149,667 | $395K |
| Renaissance Technologies | 0.00% | Add +3.3% | 148,900 | $393K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -11.6% | 147,487 | $389K |
| Wells Fargo & Company | 0.00% | Add +519.9% | 130,086 | $343K |
| Citadel Advisors | 0.00% | Add +27.9% | 111,707 | $295K |
| BlackRock, Inc. | 0.00% | Add +28.2% | 109,733 | $290K |
| Jane Street Group, LLC | 0.00% | Add +40.8% | 59,659 | $158K |
| RBF Capital, LLC | 0.01% | No change | 42,947 | $113K |
| Susquehanna International Group, LLP | 0.00% | Reduce -24.0% | 36,825 | $97K |
| Squarepoint Ops LLC | 0.00% | Reduce -35.2% | 29,866 | $79K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -53.3% | 28,243 | $75K |
| Geode Capital Management, LLC | 0.00% | No change | 24,282 | $64K |
| XTX Topco Ltd | 0.00% | New | 23,885 | $63K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 23,200 | $61K |
| American Century Companies Inc. | 0.00% | No change | 19,591 | $52K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 18,799 | $47K |
| Morgan Stanley | 0.00% | Reduce -47.3% | 16,924 | $45K |
| Sage Capital Management, LLC | 0.02% | No change | 16,750 | $44K |
| LPL Financial LLC | 0.00% | Reduce -7.5% | 13,585 | $36K |
| Barclays PLC | 0.00% | No change | 13,198 | $35K |
| TrinityBridge Ltd | 0.00% | No change | 11,675 | $31K |
| Altshuler Shaham Ltd | 0.00% | Reduce -5.4% | 11,211 | $30K |
| Mariner, LLC | 0.00% | Add +9.3% | 11,021 | $29K |
| Glass Jacobson Investment Advisors llc | 0.01% | No change | 10,540 | $28K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8,826 | $23K |
| Osaic Holdings, Inc. | 0.00% | No change | 4,317 | $10K |
| Royal Bank of Canada | 0.00% | Reduce -92.7% | 3,483 | $9K |
| Huntington National Bank | 0.00% | No change | 3,002 | $8K |
| MAI Capital Management | 0.00% | No change | 2,055 | $5K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -2.8% | 1,590 | $4K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,575 | $4K |
| NFSG Corp | 0.00% | No change | 1,000 | $3K |
| McIlrath & Eck, LLC | 0.00% | No change | 1,000 | $3K |
| Jones Financial Companies LLLP | 0.00% | Add +42.8% | 714 | $2K |
| FMR LLC | 0.00% | New | 500 | $1K |
| IFP Advisors, Inc | 0.00% | No change | 500 | $1K |
| UBS Group AG | 0.00% | Reduce -97.2% | 357 | $943 |
| Golden State Wealth Management, LLC | 0.00% | No change | 303 | $800 |
| Allworth Financial LP | 0.00% | No change | 300 | $792 |
| Hopwood Financial Services, Inc. | 0.00% | No change | 200 | $528 |
| JPMorgan Chase & Co. | 0.00% | New | 170 | $449 |
| Citigroup Inc. | 0.00% | New | 4 | $11 |
"% of holder's portfolio" is ORMP's weight in each manager's 13F, not the share of Oramed Pharmaceuticals Inc. the manager owns.